Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » GenMark Diagnostics Q1 Revenues Grow 80 Percent

GenMark Diagnostics Q1 Revenues Grow 80 Percent

May 04, 2020
|
staff reporter

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Monday that its first quarter revenues rose 80 percent, driven in part by continued sales growth of its ePlex molecular diagnostics analyzer and by its SARS-CoV-2 test.

The company also announced interim CEO Scott Mendel had been appointed President and CEO.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

What's Popular?

In Business News

  1. DiaSorin to Acquire Luminex for $1.8B

  2. 10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit

  3. Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

  4. People in the News: New Appointments at Mission Bio, Akoya Biosciences, Micronoma, More

  5. In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.